Your browser doesn't support javascript.
loading
Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and NBN Founder Variant c.657_661del5.
Sharapova, Svetlana O; Pashchenko, Olga E; Bondarenko, Anastasiia V; Vakhlyarskaya, Svetlana S; Prokofjeva, Tatjana; Fedorova, Alina S; Savchak, Ihor; Mareika, Yuliya; Valiev, Timur T; Popa, Alexander; Tuzankina, Irina A; Vlasova, Elena V; Sakovich, Inga S; Polyakova, Ekaterina A; Rumiantseva, Natalia V; Naumchik, Irina V; Kulyova, Svetlana A; Aleshkevich, Svetlana N; Golovataya, Elena I; Minakovskaya, Nina V; Belevtsev, Mikhail V; Latysheva, Elena A; Latysheva, Tatiana V; Beznoshchenko, Alexander G; Akopyan, Hayane; Makukh, Halyna; Kozlova, Olena; Varabyou, Dzmitry S; Ballow, Mark; Ong, Mei-Sing; Walter, Jolan E; Kondratenko, Irina V; Kostyuchenko, Larysa V; Aleinikova, Olga V.
Afiliación
  • Sharapova SO; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Pashchenko OE; Immunology Department, Pirogov Russian National Research Medical University, Moscow, Russia.
  • Bondarenko AV; Department of Pediatric Infectious Diseases and Pediatric Immunology, Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine.
  • Vakhlyarskaya SS; Clinical Immunology and Rheumatology Department, Russian Children's Clinical Hospital of Pirogov Russian National Research Medical University, Moscow, Russia.
  • Prokofjeva T; Pediatric Clinic, Children's Clinical University Hospital, Riga, Latvia.
  • Fedorova AS; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Savchak I; Pediatric Department, West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine.
  • Mareika Y; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Valiev TT; Chemotherapy Hemoblastoses Department, Pediatric Oncology and Hematology Research Institute of N.N. Blokhin National Cancer Research Center of the Ministry of Health of Russian Federation, Moscow, Russia.
  • Popa A; Propedevtica of Childhood Diseases Faculty, Pirogov Russian National Research Medical University, Moscow, Russia.
  • Tuzankina IA; Institute of Immunology and Physiology of the Branch of the Russian Academy of Sciences, Federal State Autonomous Educational Intuition of Higher Professional Education (Ural Federal University of a Name of the First President of Russia, B.N. Yeltsin), Yekaterinburg, Russia.
  • Vlasova EV; Clinical Department, Regional Children's Clinical Hospital №1, Yekaterinburg, Russia.
  • Sakovich IS; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Polyakova EA; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Rumiantseva NV; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus.
  • Naumchik IV; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus.
  • Kulyova SA; Pediatric Oncology Department, N.N. Petrov National Medical Research Center of Oncology, St-Petersburg, Russia.
  • Aleshkevich SN; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Golovataya EI; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus.
  • Minakovskaya NV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Belevtsev MV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Latysheva EA; Immunopathology Department, NRC Institute of Immunology FMBA, Moscow, Russia.
  • Latysheva TV; Immunopathology Department, NRC Institute of Immunology FMBA, Moscow, Russia.
  • Beznoshchenko AG; Department of Pediatric Oncology/Hematology, Regional Children's Hospital, Ryazan, Russia.
  • Akopyan H; Institute of Hereditary Pathology of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine.
  • Makukh H; Institute of Hereditary Pathology of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine.
  • Kozlova O; West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine.
  • Varabyou DS; Department of Ecologic Geography, Belarusian State University, Minsk, Belarus.
  • Ballow M; Department of Pediatrics, University of South Florida at Johns Hopkins All Children's Hospital, Saint Petersburg, FL, United States.
  • Ong MS; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care, Boston, MA, United States.
  • Walter JE; Department Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, Saint Petersburg, FL, United States.
  • Kondratenko IV; Clinical Immunology and Rheumatology Department, Russian Children's Clinical Hospital of Pirogov Russian National Research Medical University, Moscow, Russia.
  • Kostyuchenko LV; Pediatric Department, West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine.
  • Aleinikova OV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Front Immunol ; 11: 602482, 2020.
Article en En | MEDLINE | ID: mdl-33488600
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Efecto Fundador / Proteínas de Ciclo Celular / Neoplasias Hematológicas / Síndrome de Nijmegen / Trastornos Linfoproliferativos Tipo de estudio: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Efecto Fundador / Proteínas de Ciclo Celular / Neoplasias Hematológicas / Síndrome de Nijmegen / Trastornos Linfoproliferativos Tipo de estudio: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article